Is science driving emerging adults from religion? Our Sinai and Synapses Fellows discuss.
Arvin Gouw is the vice president for research and development overseeing the BeHEARD (Help Empower & Accelerate Research Discoveries) and RGTF (Rare Genomics Task Force) divisions of Rare Genomics Institute, where he leads crowdfunding efforts for rare disease personalized medicine research, predominantly for children, and develops novel online and mobile platforms to connect patients to medical experts. Arvin is currently a fellow at Stanford and Berkeley studying the role of metabolism in cancer and stem cells, where his work is under the entrepreneurship program of SPARK at Stanford, while leading the entrepreneurship program, BPEP (Berkeley Postdoc Entrepreneur Program) at Berkeley. He is also an affiliate faculty at Harvard, given his interest in the intersection between science, policy and religion regarding genomics ethics. Prior to Stanford, he served as associate pastor in Philadelphia, during which he did his fellowship on science and theology at Princeton Theological Seminary. Arvin received his Ph.D. in pathobiology from Johns Hopkins University School of Medicine, M.Phil in philosophy from University of Pennsylvania, M.A. in theology from the Ecumenical Institute of Theology of St. Mary’s Seminary & University, M.A. in endocrinology and B.A. in molecular biology both from UC Berkeley.